TelAmlo 5 mg+40 mg (Tablet)
Unit Price: ৳ 12.50 (3 x 10: ৳ 375.00)
Strip Price: ৳ 125.00
Medicine Details
Category | Details |
---|---|
Generic | Amlodipine besilate telmisartan |
Company | Unimed unihealth pharmaceuticals ltd |
Also available as |
Indications
- Treatment of hypertension
- Use as initial therapy in patients who need multiple drugs to achieve blood pressure goals
Pharmacology
- Combination of Telmisartan and Amiodipine
- Telmisartan: angiotensin receptor blocker (ARB), selective angiotensin II antagonist
- Amiodipine: dihydropyridine calcium-channel blocker (CCB), peripheral arterial vasodilator
Dosage & Administration
- Initial dose: 40/5 mg once daily
- Starting larger blood pressure reductions with 80/5 mg once daily
- Add-on therapy for patients not adequately controlled with other medications
- Replacement therapy for patients receiving components separately
- Maximum recommended dose: 80/10 mg once daily
Interaction
- No clinically significant interactions with specific drugs observed
- Telmisartan not metabolized by the cytochrome P450 system
- Amiodipine safely administered with various other drugs
Contraindications
- Known hypersensitivity to the product or its components
- Pregnancy & lactation
- Biliary obstructive disorders, severe hepatic impairment, hypotension, cardiogenic shock, left ventricle outflow tract obstruction
Side Effects
- Dizziness
- Peripheral edema
- Migraine
- Headache
- Bradycardia
- Hypotension
- Abdominal pain
- Diarrhea
- Nausea
- Pruritus
- Myalgia
- Erectile dysfunction
- Chest pain
- Fatigue
Pregnancy & Lactation
- Pregnancy Categories C (first trimester) and D (second and third trimesters)
- Excretion in human milk unknown
- Discontinue nursing or drug after considering importance to the mother
Precautions & Warnings
- Avoid fetal or neonatal exposure
- Correct volume or salt depletion before initiating therapy
- Monitor for worsening heart failure
- Avoid concomitant use of ACE inhibitor and angiotensin receptor blocker
- Titrate slowly in patients with hepatic or severe renal impairment
Use in Special Populations
- Pediatric use not established
- Initial therapy not recommended in patients ≥75 years old or with hepatic impairment
Overdose Effects
- Telmisartan: hypotension, dizziness, tachycardia, bradycardia
- Amiodipine: excessive peripheral vasodilation, marked hypotension, reflex tachycardia
Therapeutic Class
- Combined antihypertensive preparations
Storage Conditions
- Do not store above 30°C
- Protect from light and high humidity
- Keep out of the reach of children